Respiratory Failure in a Pediatric Patient with Biventricular Assist Devices: Identification and Novel Management of Inflow Cannula Obstruction.

ASAIO J

From the *Section of Critical Care Medicine, Department of Pediatrics, Children's Hospital Colorado, Aurora, Colorado; †Division of Cardiology, Department of Pediatrics, Children's Hospital Colorado Heart Institute and University of Colorado Denver, Aurora, Colorado; and ‡Division of Cardiothora

Published: April 2016


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Respiratory failure after ventricular assist device (VAD) placement may threaten transplant candidacy and can be lethal. Refractory respiratory failure may require addition of extracorporeal membrane oxygenation (ECMO) support. Providing ECMO in a VAD-supported patient is uniquely challenging, particularly in the case of LVAD inflow cannula obstruction in a pediatric patient who may be more prone to cannula obstruction. Surgical intervention to alleviate obstruction may not be feasible. Here, we present a novel nonsurgical strategy for conversion to ECMO in a VAD-supported pediatric patient with respiratory failure because of LVAD inflow cannula obstruction.

Download full-text PDF

Source
http://dx.doi.org/10.1097/MAT.0000000000000217DOI Listing

Publication Analysis

Top Keywords

respiratory failure
16
cannula obstruction
16
pediatric patient
12
inflow cannula
12
ecmo vad-supported
8
lvad inflow
8
obstruction
5
respiratory
4
failure pediatric
4
patient
4

Similar Publications

BackgroundCoronavirus Disease 2019 (COVID-19) has led to dramatic changes including social distancing, closure of schools, travel bans, and issues of stay-at-home orders. The health-care field has been transformed with elective procedures and on-site visits being deferred. Telemedicine has emerged as a novel mechanism to continue to provide care.

View Article and Find Full Text PDF

Sudden Death Caused by Bilateral Diaphragmatic Eventration in Myotonic Dystrophy Type 1.

Am J Forensic Med Pathol

September 2025

Department of Pathology, St Louis University School of Medicine, Office of the Medical Examiner - City of St. Louis, St. Louis, MO.

Myotonic dystrophy type 1, or dystrophia myotonica type 1 (DM1), is a multisystem disorder inherited in an autosomal dominant manner. It is caused by a CTG tri-nucleotide expansion in the 3'-untranslated region (3'-UTR) of the dystrophia myotonia protein kinase (DMPK) gene. Core clinical features include progressive skeletal muscle weakness, myotonia, and systemic complications, with premature mortality most often due to respiratory or cardiac dysfunction.

View Article and Find Full Text PDF

Comparative Analysis of COVID-19 Gene Target Dropout/Failure Results using Thermofisher TaqPath COVID-19 Combo Kit and Nextstrain CoVariants Genomic Databases.

J Healthc Sci Humanit

January 2024

Assistant Professor & Clinical Coordinator, Health Informatics Program, School of Health Professions, State University of New York Downstate Health Sciences University, 450 Clarkson Avenue, MSC 94, Brooklyn, NY 11203, (718) 270-7738, Fax: (718) 270-7739 Email:

COVID-19 variants continue to infect thousands of people even though the end of the pandemic was announced on May 11, 2023. Nextstrain CoVariants (CoVariants) genomic databases provide detailed information about more than 31 variants of COVID-19 viruses that have been identified through genomic sequencing, showing the mutations they carry. Mutated viruses may yield a negative result for a gene target using a PCR test that has a positive COVID-19 test result.

View Article and Find Full Text PDF